Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
4,601	27.13799	0	male	0	11	923	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	0	30,684	20,034.7188	19,159	29.5	white	22.898438	29	0.910889	0.87793	1	0	0	no	0.7	0.7	no dnr	11	114	9.699219	103	20	36.79688	361.875	null	0.5	0.799927	123	7.469727	144	17	800	0	0	null	0
4,602	33.53	0	female	0	4	922	CHF	COPD/CHF/Cirrhosis	2	14	under $11k	0	5,940	3,547.0684	3,059	5	black	10.099609	6	0.966919	0.94397	1	1	0	no	null	null	no dnr	4	146	20.898438	60	28	38.5	350	null	null	1.5	147	7.459961	102	31	2,195	0	null	no(M2 and SIP pres)	0.494751
4,603	70.04199	1	male	1	14	14	COPD	COPD/CHF/Cirrhosis	1	8	null	0	58,371	38,666.5	33,197	36	white	28.5	47	0.688965	0.521973	2	0	0	no	0.65	0.5	dnr after sadm	14	123	20	135	33	38.79688	212.5	2.299805	1	0.699951	143	7.529297	98	14	1,615	null	0	<2 mo. follow-up	0
4,604	48.83798	0	male	0	101	921	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	>$50k	0	562,579	343,860.25	315,256	44.5	white	28	49	0.724976	0.639893	67	0	0	no	0.9	0.9	no dnr	101	58	18	120	10	36.69531	151	1.599854	0.399963	2.5	141	7.359375	70	37	1,935	null	1	adl>=4 (>=5 if sur)	1
4,605	23.99199	0	male	0	35	921	Coma	Coma	2	13	under $11k	44	204,389	143,170.875	135,740	27	white	30	53	0.626953	0.565918	8	0	0	no	null	null	no dnr	35	128	22.097656	150	40	36.5	288	null	1.299805	2.599609	135	7.30957	214	45	2,110	null	1	no(M2 and SIP pres)	1
4,606	49.383	1	female	0	5	231	Lung Cancer	Cancer	1	null	null	0	7,343	3,871.666	2,215	11	white	19.097656	14	0.702881	0.416992	1	0	0	metastatic	1	0.9	no dnr	5	108	12.099609	135	35	36.09375	256.625	2.799805	0.299988	0.5	143	7.5	155	12	3,155	null	null	null	2.093262
4,607	61.67599	1	male	1	5	5	Colon Cancer	Cancer	1	8	$11-$25k	0	2,958	1,935.3555	1,559	15	black	34.398438	44	0.447998	0.136993	1	0	0	metastatic	0	0	no dnr	5	105	9.298828	135	6	35.79688	395.1875	null	5.199219	5.099609	137	7.469727	383	101	1,040	null	7	<2 mo. follow-up	7
4,608	74.97095	0	male	0	26	920	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	96,936	58,131.75	65,039	22.25	white	26.296875	41	0.674927	0.579956	6	0	0	no	0.65	0.6	no dnr	26	70	14.199219	120	29	38.79688	106	null	null	1.099854	133	7.5	211	44	1,175	null	0	null	0
4,609	76.53699	1	female	1	3	3	MOSF w/Malig	ARF/MOSF	1	16	$25-$50k	61	17,981	10,559.3828	8,841	50	black	73.296875	76	0	0	2	1	0	yes	null	null	no dnr	3	58	18.199219	70	14	39.09375	96.65625	null	null	1.199951	141	7.459961	104	36	1,550	null	0	<2 mo. follow-up	0
4,610	63.96997	1	male	0	16	113	CHF	COPD/CHF/Cirrhosis	1	8	null	41	33,433	19,486.6562	18,911	22.666656	black	51.195313	86	0.036995	0.003	1	0	0	no	0.3	0.15	dnr after sadm	3	66	16.597656	64	28	32.19531	null	2.299805	2.099609	1.399902	151	null	189	18	125	1	6	no(M2 and SIP pres)	6
4,611	80.58295	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	null	0	48,776	28,987.375	36,857	50	white	39.296875	62	0.258972	0.153992	12	1	0	no	0.1	0	dnr after sadm	2	117	7.399414	100	24	36.39844	240	null	null	1.299805	141	7.449219	87	22	100	null	null	<2 mo. follow-up	2.908203
4,612	75.56195	0	male	0	34	917	ARF/MOSF w/Sepsis	ARF/MOSF	1	6	null	0	75,121	48,257.625	49,827	12.75	white	23.398438	30	0.704956	0.615967	18	0	0	no	null	null	no dnr	34	80	5.699219	125	22	35.69531	null	null	1	1.299805	142	null	78	21	1,000	null	6	no(M2 and SIP pres)	6
4,613	83.46594	1	female	0	17	23	Coma	Coma	1	8	under $11k	61	41,887	null	null	24	black	21.097656	48	0.238983	0.173981	4	0	0	no	0.1	0.1	dnr after sadm	2	128	7.699219	110	12	35.39844	264	null	24	10.898438	131	7.509766	100	68	2,980	null	0	<2 mo. follow-up	0
4,614	78.12195	1	male	0	13	341	COPD	COPD/CHF/Cirrhosis	4	6	under $11k	0	23,784	14,434.2188	16,695	20	white	24.597656	40	0.654907	0.477966	1	1	0	yes	0.75	0.6	no dnr	13	57	3.299805	115	12	36	117.76562	2.299805	0.5	7.899414	126	7.369141	374	73	900	3	5	SIP>=30	5
4,615	59.66599	1	male	0	5	233	Lung Cancer	Cancer	1	12	$11-$25k	0	7,854	4,179	3,162	14	white	17.5	16	0.710938	0.429993	1	0	0	metastatic	0.8	0.5	no dnr	5	102	12.898438	114	24	36.39844	365.1875	3.799805	0.399963	1.299805	144	7.429688	199	15	null	1	2	null	2
4,616	37.86697	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	37	35,427	24,140.5781	20,114	40.5	black	44.695313	87	0.315979	0.201996	1	1	0	no	0.1	0.05	dnr after sadm	8	80	9.398438	75	8	37.79688	368	null	null	0.5	142	7.419922	117	4	4,520	null	null	<2 mo. follow-up	2.927734
4,617	73.59296	0	male	0	30	916	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	41	100,898	59,514.1562	64,135	33	white	28.296875	42	0.496948	0.378967	2	0	0	no	0.5	0.3	no dnr	30	115	16.796875	115	12	36.19531	128.5625	null	0.699951	4.899414	133	7.40918	108	72	4,185	null	0	no(M2 and SIP pres)	0
4,618	68.33698	0	male	0	94	916	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	0	324,557	193,135	211,562	34.75	white	27.5	36	0.698975	0.60791	4	0	0	no	0.75	0.6	no dnr	94	73	5.099609	128	20	36.39844	null	2.5	0.399963	0.699951	132	null	520	6	200	null	0	adl>=4 (>=5 if sur)	0
4,619	37.55499	0	male	0	18	916	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	null	0	58,201	41,127.0938	38,203	27	white	37.898438	60	0.655884	0.556885	2	0	0	no	0.8	0.7	no dnr	18	108	5.399414	135	35	38.39844	142.5	1.5	8.5	1.099854	145	7.399414	52	20	2,180	null	0	no(M2 and SIP pres)	0
4,620	68.58295	1	male	1	6	6	Lung Cancer	Cancer	1	21	null	9	9,984	5,991.3438	6,257	7	white	19.199219	43	0.615967	0.300964	1	0	0	metastatic	0.4	0.2	dnr after sadm	5	115	14.5	145	36	36.5	253.3125	2.899902	0.199982	2	134	7.469727	122	20	5,510	null	null	<2 mo. follow-up	2.272461
4,621	54.021	0	male	0	23	914	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	0	89,819	52,582.5938	52,400	28.666656	white	24.597656	19	0.820923	0.760986	2	0	0	no	0.9	0.85	no dnr	23	92	5.099609	70	20	37	null	1	3.799805	0.799927	136	null	69	10	4,900	null	0	SIP>=30	0
4,622	18.84999	0	male	0	27	914	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	$25-$50k	0	112,985	72,790.5	68,755	18	white	25.398438	48	0.889893	0.850952	4	0	0	no	0.75	0.75	no dnr	27	93	22.398438	100	10	37.59375	182.5	2.399902	6.199219	5.899414	137	7.319336	99	97	3,040	0	0	no(M2 and SIP pres)	0
4,623	55.96698	0	female	0	22	913	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	null	0	81,191	48,240.375	52,100	25.666656	white	18.398438	30	0.869995	0.823975	5	0	0	no	0.9	0.8	no dnr	22	163	14.398438	55	14	38.29688	245	3.799805	null	1.399902	148	7.519531	192	16	3,005	null	0	no(M2 and SIP pres)	0
4,624	67.81696	0	male	0	16	913	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	0	36,085	22,808.9688	21,588	18.666656	white	16	35	0.873901	0.828979	3	0	0	no	0.98	0.9	no dnr	16	88	6.599609	60	42	38.39844	255	2.799805	0.399963	0.799927	143	7.439453	96	16	5,430	null	null	no(M2 and SIP pres)	2.101074
4,625	43.87997	0	female	0	23	912	COPD	COPD/CHF/Cirrhosis	2	9	$25-$50k	0	35,225	24,241.7344	26,822	15	white	36.796875	51	0.759888	0.618896	1	0	0	no	0.85	0.75	no dnr	23	75	6	60	8	38.09375	360	2.699707	null	0.599976	137	7.479492	90	6	3,140	6	6	no(M2 and SIP pres)	6
4,626	73.35199	1	male	0	6	259	Colon Cancer	Cancer	1	18	under $11k	0	8,575	4,780.0039	3,073	11	white	22.898438	6	0.698975	0.411987	1	0	0	metastatic	0.7	0.5	no dnr	6	78	6.199219	62	20	36.5	null	3.599609	0.699951	1.399902	135	null	78	44	1,750	1	0	no(M2 and SIP pres)	0
4,627	66.95099	1	male	0	6	652	Colon Cancer	Cancer	1	12	$25-$50k	0	9,823	5,222.8516	2,767	12	white	3.899902	16	0.930908	0.837891	1	0	0	metastatic	0.8	0.5	no dnr	6	144	12.298828	70	37	35.59375	null	null	null	2.099609	137	null	190	126	1,700	0	0	no(M2 and SIP pres)	0
4,628	27.28499	0	male	0	17	911	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	null	0	54,747	33,137.2188	36,116	28	white	21.796875	24	0.917969	0.887939	1	0	0	no	0.7	0.7	no dnr	17	65	10.699219	95	25	36.29688	120	1.899902	null	3	127	7.379883	132	37	170	null	0	no(M2 and SIP pres)	0
4,629	65.23199	0	male	0	38	909	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	90,020	53,483.9688	48,524	22.5	white	24.597656	37	0.764893	0.689941	4	0	0	no	0.75	0.65	no dnr	38	57	7.199219	145	24	36.39844	null	null	2.799805	1.399902	130	null	92	46	1,700	null	0	no(M2 and SIP pres)	0
4,630	62.27197	1	male	0	12	44	Lung Cancer	Cancer	1	10	$11-$25k	0	12,126	8,072.0898	8,354	6	white	17	11	0.713989	0.43396	1	0	0	metastatic	0.6	0.2	dnr after sadm	5	58	7.799805	65	44	35	188.5625	null	0.399963	1.799805	136	7.429688	191	25	330	null	6	<2 mo. follow-up	6
4,631	64.69495	1	male	1	18	18	CHF	COPD/CHF/Cirrhosis	4	7	$11-$25k	37	75,950	43,130.25	46,996	35.666657	white	27.398438	40	0.60791	0.419983	2	0	0	no	0.9	0.8	dnr after sadm	17	30	13.599609	0	0	37.19531	152.5	null	null	1.5	131	7.419922	169	25	72	null	4	<2 mo. follow-up	4
4,632	54.89697	1	female	0	8	127	Lung Cancer	Cancer	1	16	>$50k	0	6,629	4,383.3828	5,313	4.5	white	19.796875	3	0.675903	0.378967	1	0	0	metastatic	0	0	dnr after sadm	2	139	16.898438	70	22	37.69531	280.9375	null	0.399963	1.799805	144	7.349609	99	66	2,300	null	5	adl>=4 (>=5 if sur)	5
4,633	47.96198	1	male	0	11	814	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	null	0	37,890	null	null	28	black	23.5	47	0.844971	0.791992	3	1	0	no	1	1	no dnr	11	55	33.195313	50	12	39.09375	120	null	2.299805	4.799805	131	7.349609	69	75	144	2	4	SIP>=30	4
4,634	57.84	0	female	0	140	906	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	0	null	581,140	494,838	37.75	white	24	45	0.701904	0.612915	66	0	0	yes	null	null	no dnr	140	148	20.199219	115	28	36.29688	126.65625	2.5	null	3.799805	147	7.439453	69	64	46	null	0	adl>=4 (>=5 if sur)	0
4,635	63.73199	0	female	0	47	903	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	143,396	83,986.8125	83,146	38.75	white	34.296875	57	0.540894	0.426941	1	0	0	yes	0.6	0.5	no dnr	47	68	12	100	36	35	256.625	null	null	0.899902	137	7.469727	173	30	2,435	null	0	no(M2 and SIP pres)	0
4,636	72.32898	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	122,706	70,672.0625	72,596	38.666657	white	26.5	48	0.680908	0.586914	7	0	0	no	0.6	0.6	dnr after sadm	8	115	0.699951	30	11	36.39844	188.5625	3.099609	0.899902	1	136	7.469727	96	18	4,470	null	0	<2 mo. follow-up	0
4,637	62.89899	0	male	0	156	903	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$11-$25k	0	null	483,192.5	424,471	48.5	white	31.199219	44	0.587891	0.478943	28	0	0	no	0.4	0.064	no dnr	156	63	15.199219	65	24	37.79688	257.125	2.299805	0.699951	1.699951	143	7.369141	93	47	3,015	null	1	adl>=4 (>=5 if sur)	1
4,638	44.16699	1	female	1	53	53	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	141,044	88,699.5	46,605	24.25	hispanic	29.296875	74	0.802979	0.736938	1	0	0	no	0.7	0.65	no dnr	53	58	27.699219	130	28	36.5	185.6875	null	0.599976	1.399902	138	7.479492	337	68	3,440	null	0	<2 mo. follow-up	0
4,639	85.89996	1	male	1	57	57	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	253,935	147,299.375	81,815	41.25	white	20.796875	37	0.711914	0.625	2	0	0	yes	null	null	dnr after sadm	55	100	9.398438	85	22	36.59375	null	null	0.599976	0.899902	137	null	129	16	1,900	null	0	<2 mo. follow-up	0
4,640	58.13797	1	male	0	32	681	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$25-$50k	0	117,341	67,746.375	62,858	28.5	white	29.5	54	0.677979	0.582886	10	0	0	no	null	null	no dnr	32	72	18.398438	100	14	37.79688	155	3	null	3.099609	131	7.449219	102	53	1,990	null	2	adl>=4 (>=5 if sur)	2
4,641	66.97296	1	male	1	10	10	MOSF w/Malig	ARF/MOSF	1	19	$11-$25k	0	27,791	17,151.7656	17,346	13.5	white	27	31	0.542969	0.428955	9	0	0	yes	0.7	0.4	dnr after sadm	1	72	8.798828	105	40	38	230	3.799805	0.5	1.199951	139	7.459961	94	13	2,830	null	0	<2 mo. follow-up	0
4,642	81.26996	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	null	0	69,968	39,407.5625	40,857	45.5	white	49.695313	80	0.056	0.017998	5	0	0	no	0.25	0.25	no dnr	11	135	17.296875	105	12	36.69531	514.25	2.699707	0.5	2.299805	140	7.259766	353	38	870	null	0	<2 mo. follow-up	0
4,643	61.771	1	male	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	51,834	30,533.4219	30,175	31	white	33.5	44	0.574951	0.464966	1	0	0	yes	0.4	0.2	dnr after sadm	4	78	6.899414	115	24	38.5	186.65625	2.799805	0.599976	1.199951	130	7.429688	95	32	3,335	null	0	<2 mo. follow-up	0
4,644	44.73398	1	female	0	6	554	Lung Cancer	Cancer	1	18	>$50k	0	8,851	4,862.5469	2,920	11	white	6.5	5	0.885986	0.741943	1	0	0	metastatic	0.7	0.5	no dnr	6	72	5.399414	105	24	35.19531	null	3.299805	2.799805	1.5	123	null	108	34	2,950	0	0	no(M2 and SIP pres)	0
4,645	63.69299	0	female	0	5	902	COPD	COPD/CHF/Cirrhosis	1	null	null	0	4,883	3,504.1641	3,108	12	black	16.796875	19	0.898926	0.829956	1	0	0	no	0.75	0.5	no dnr	5	93	7.599609	70	20	36.29688	228.5625	3.799805	0.5	2.799805	135	7.40918	220	61	1,900	1	0	no(M2 and SIP pres)	0
4,646	57.61298	1	male	0	9	604	Colon Cancer	Cancer	1	12	$25-$50k	0	13,696	8,415.9453	7,827	9	white	17.699219	6	0.820923	0.612915	1	0	0	metastatic	null	null	no dnr	9	107	5.199219	70	18	36.39844	null	3.799805	0.399963	1	138	null	103	11	1,000	null	null	no(M2 and SIP pres)	2.310547
4,647	74.79797	0	female	0	14	901	Colon Cancer	Cancer	1	12	$11-$25k	0	22,498	13,941.4922	13,036	9.666664	white	14.798828	9	0.828979	0.62793	1	0	0	metastatic	null	null	no dnr	14	103	11.5	110	26	36.09375	246.65625	1.699951	5.099609	3.899902	136	7.429688	319	73	2,705	0	0	no(M2 and SIP pres)	0
4,648	24.709	0	male	0	27	900	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	0	135,950	75,986.9375	73,674	37.5	black	40.5	75	0.687988	0.594971	1	0	0	no	0.5	0.5	no dnr	27	72	16.597656	55	26	36.19531	177.125	2.399902	0.399963	1.199951	141	7.419922	92	19	5,445	null	0	null	0
4,649	92.31995	1	female	0	13	32	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	23,363	14,359.7891	13,182	22.5	white	73.390625	75	0	0	1	0	0	yes	0.5	0.25	dnr after sadm	2	117	6.199219	75	22	36.39844	null	4.199219	0.5	0.799927	140	null	84	9	2,960	null	3	<2 mo. follow-up	3
4,650	47.31299	1	male	0	40	76	Colon Cancer	Cancer	1	null	null	0	55,251	33,087.5312	30,881	10.75	white	16.699219	16	0.849976	0.668945	1	0	0	metastatic	null	null	no dnr	40	55	14.898438	130	30	35.69531	296	null	null	1.299805	136	7.339844	151	44	1,940	null	null	null	2.266602
4,651	56.41098	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	1	6	under $11k	0	106,196	54,926.6562	56,044	52	white	79.6875	94	0	0	3	0	0	no	0.75	0.75	dnr after sadm	14	72	32	115	28	38	185	2.099609	5	1.199951	148	7.439453	134	26	6,115	null	0	<2 mo. follow-up	0
4,652	51.51797	1	female	0	18	160	Lung Cancer	Cancer	1	11	$11-$25k	0	25,189	16,071.8516	17,381	6.666664	white	17	11	0.738892	0.471985	1	0	0	metastatic	1	0.9	no dnr	18	135	12.199219	115	10	38.29688	392	2.099609	14.099609	1.199951	127	7.549805	229	17	1,545	0	1	no(M2 and SIP pres)	1
4,653	76.42395	1	male	0	8	149	Colon Cancer	Cancer	1	11	under $11k	0	9,101	5,863.6836	5,795	5.5	black	24.199219	31	0.662964	0.360962	1	0	0	metastatic	0.35	0.1	dnr after sadm	2	102	6.399414	115	20	36.5	null	null	0.299988	0.799927	135	null	95	3	2,305	1	0	no(M2 and SIP pres)	0
4,654	47.72897	1	male	0	23	61	Lung Cancer	Cancer	1	16	$25-$50k	0	37,925	22,524.75	26,891	11.666664	white	30.296875	23	0.42395	0.118988	1	0	0	metastatic	null	null	no dnr	23	98	7.699219	111	20	36.5	null	2.299805	4.099609	1	140	null	141	26	200	0	3	null	3
4,655	62.08099	1	male	0	16	67	Lung Cancer	Cancer	1	14	$11-$25k	0	34,952	20,978.7188	18,468	16.333328	black	28.296875	18	0.432983	0.125	1	0	0	metastatic	0.99	0.9	no dnr	16	62	12.898438	145	44	39.59375	192.5	null	null	1.099854	137	7.469727	138	19	5,125	null	0	null	0
4,656	77.60699	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	37	48,632	28,300.7969	30,776	42	white	28	44	0.5	0.382996	2	0	0	no	0.4	0.25	dnr after sadm	4	0	24.597656	0	10	38.5	157.5	1.799805	0.599976	2.599609	148	7.339844	172	59	832	null	2	<2 mo. follow-up	2
4,657	77.17694	1	male	0	46	57	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	41	97,799	60,579.9688	18,902	28.5	black	20.796875	21	0.595947	0.487976	14	1	1	no	0.8	0.8	no dnr	46	45	13.199219	110	0	39	126.51562	null	null	2.899902	123	7.519531	83	58	230	null	null	<2 mo. follow-up	5.62793
4,658	72.83795	1	male	0	4	152	CHF	COPD/CHF/Cirrhosis	2	12	null	0	6,601	4,359.1523	3,777	16	white	28.5	48	0.701904	0.539917	1	0	0	no	null	null	no dnr	4	42	21.296875	60	10	36.69531	370	null	null	5.599609	128	7.30957	377	106	500	null	null	no(M2 and SIP pres)	2.127441
4,659	77.87	1	female	1	7	7	Coma	Coma	2	16	under $11k	61	46,219	26,834.6406	29,943	13.5	black	32.296875	54	0.011	0.004	15	0	0	yes	0.15	0.05	dnr after sadm	6	103	18.097656	95	10	36.59375	288	2.399902	1.299805	1.299805	129	7.5	104	19	2,745	null	null	<2 mo. follow-up	2.644043
4,660	53.599	0	female	0	10	895	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	7,853	5,763.418	6,893	9	black	19.796875	8	0.892944	0.820923	1	0	0	no	0.9	0.7	no dnr	10	135	8.099609	120	4	38	283.3125	3.299805	null	1	139	7.439453	971	22	2,295	0	0	no(M2 and SIP pres)	0
4,661	71.362	0	female	0	20	892	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	31,418	20,014.6719	19,758	19	black	24.097656	37	0.783936	0.713989	1	0	0	no	0.9	0.9	no dnr	20	107	5.5	55	26	36.19531	186	null	0.799927	2.099609	141	7.419922	325	53	5,200	0	0	no(M2 and SIP pres)	0
4,662	68.78894	1	female	1	21	21	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	null	0	177,484	102,778.688	103,117	49	white	27.296875	70	0.664917	0.567993	12	0	0	no	0.8	0.7	dnr after sadm	18	80	14.398438	60	22	36.19531	null	3.599609	0.599976	0.899902	134	null	336	17	1,600	null	1	<2 mo. follow-up	1
4,663	73.99298	1	male	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	under $11k	0	112,800	66,367.5	65,955	31.333328	white	26.097656	56	0.498962	0.380981	24	1	0	metastatic	0.6	0.35	no dnr	20	63	24.097656	115	30	35.19531	150	2.5	17.597656	4.799805	140	7.379883	328	80	8	0	0	<2 mo. follow-up	0
4,664	60.70099	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	5	$25-$50k	0	100,215	56,954.2812	58,198	54.5	white	37.5	71	0.527954	0.412964	2	0	0	no	0.5	0.5	no dnr	10	70	19.597656	80	12	35.89844	167.5	null	null	5.5	134	7.379883	84	100	2,100	null	0	<2 mo. follow-up	0
4,665	44.63797	1	female	0	10	39	Lung Cancer	Cancer	2	12	under $11k	0	15,027	8,958.0078	9,747	13.5	white	39	44	0.182983	0.014999	1	0	0	metastatic	0.8	0.2	dnr after sadm	3	63	6.199219	105	30	36.89844	123.625	null	null	1.099854	132	7.459961	118	23	4,505	5	5	<2 mo. follow-up	5
4,666	60.69498	0	male	0	27	889	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	0	96,528	56,634.75	59,375	29.5	white	23	37	0.805908	0.741943	4	0	0	no	0.3	0.2	dnr after sadm	8	52	32.5	135	48	38.39844	94	null	1	0.599976	140	7.419922	117	7	3,060	null	0	adl>=4 (>=5 if sur)	0
4,667	59.44699	1	female	1	5	5	Coma	Coma	1	8	under $11k	89	24,836	15,311.375	13,256	42	black	23.796875	31	0.092987	0.054993	8	0	0	metastatic	0.05	0	dnr after sadm	3	64	67.09375	80	28	39	null	null	null	1.399902	140	null	11	26	1,000	null	null	<2 mo. follow-up	2.894531
4,668	75.95898	1	male	1	16	16	COPD	COPD/CHF/Cirrhosis	5	12	$25-$50k	0	83,494	49,170.5312	47,284	33.666657	white	30.597656	48	0.447998	0.246979	6	0	0	yes	0.5	0.5	dnr after sadm	15	70	11.898438	105	10	38.69531	154.28125	null	null	1.299805	132	7.40918	151	19	2,450	null	1	<2 mo. follow-up	1
4,669	58.37598	1	female	0	9	287	Cirrhosis	COPD/CHF/Cirrhosis	2	12	null	0	29,065	19,337.3438	18,850	19	white	25	41	0.715942	0.557983	1	0	0	no	0.7	0.5	no dnr	9	132	28.398438	135	8	38.79688	270	null	2.599609	1.399902	137	7.30957	92	48	3,180	0	0	no(M2 and SIP pres)	0
4,670	73.22095	0	female	0	5	887	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	5,317	3,414.8769	3,727	13	white	17.898438	14	0.849976	0.75293	1	0	0	no	0.75	0.75	no dnr	5	135	10.699219	65	30	38	233	null	null	0.599976	137	7.429688	99	10	5,195	0	2	no(M2 and SIP pres)	2
4,671	91.48798	1	female	1	6	6	Coma	Coma	2	null	under $11k	0	46,934	null	null	37	black	26.699219	55	0.168976	0.113998	20	0	0	yes	0	0	dnr after sadm	1	115	9.699219	75	31	38.79688	232	2.599609	0.399963	12.898438	144	7.389648	107	83	5,112	null	3	<2 mo. follow-up	3
4,672	60.28497	1	female	0	4	593	Colon Cancer	Cancer	1	9	under $11k	0	2,439	2,092.8027	2,254	8	white	11.599609	5	0.883911	0.735962	1	0	0	metastatic	0.8	0.6	no dnr	4	115	27.398438	125	10	36.29688	182.5	2.399902	0.699951	0.399963	137	7.439453	81	20	900	0	null	SIP>=30	0.494751
4,673	77.44299	1	male	1	31	31	COPD	COPD/CHF/Cirrhosis	3	8	under $11k	0	143,014	81,730	75,129	43	white	26.699219	45	0.678955	0.508911	1	0	0	no	0.5	0.5	dnr after sadm	27	83	10.599609	65	20	36.09375	null	2.899902	0.399963	1	141	null	139	11	4,900	null	0	<2 mo. follow-up	0
4,674	67.39496	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	under $11k	0	39,396	24,119.1719	22,701	48.5	white	35.296875	70	0.569946	0.457947	1	0	0	no	0.02	0.02	dnr after sadm	7	75	5.299805	60	20	36.5	null	4.5	0.5	1.099854	142	null	98	12	5,925	null	0	<2 mo. follow-up	0
4,675	55.01398	1	male	0	7	24	Lung Cancer	Cancer	2	4	$11-$25k	0	6,700	4,328.8984	5,167	6.5	white	23	26	0.598999	0.280945	1	0	0	metastatic	0.5	0.1	dnr before sadm	0	115	12.099609	80	16	38.29688	91.25	2.399902	0.5	0.899902	142	7.40918	149	10	3,910	3	3	<2 mo. follow-up	3
4,676	47.53699	0	male	0	14	883	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	73,925	41,813.8438	45,206	20.666656	white	24.699219	24	0.815918	0.754883	6	0	0	no	0.85	0.8	no dnr	14	72	11.599609	105	16	37.79688	180	null	null	1.899902	146	7.40918	255	58	1,675	0	0	null	0
4,677	72.00299	1	female	1	11	11	Coma	Coma	1	14	null	89	29,982	18,713.8125	16,394	23	white	20.296875	12	0.267944	0.199982	2	0	0	no	0.1	0.05	dnr after sadm	6	70	null	76	16	36.29688	null	null	null	0.5	138	null	90	4	null	null	1	<2 mo. follow-up	1
4,678	74.91895	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	3	$11-$25k	0	63,505	35,324.125	34,675	48	white	53.695313	113	0.019997	0.004	13	0	0	no	0.02	0.02	dnr after sadm	3	138	10.699219	125	10	38.69531	197.5	null	null	2.599609	133	7.519531	133	35	3,395	null	0	<2 mo. follow-up	0
4,679	30.86699	1	male	1	44	44	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	37	93,251	57,726.3438	55,655	18.5	white	42.195313	63	0.365967	0.247986	5	0	0	no	null	null	dnr after sadm	43	99	10.199219	106	20	37	null	null	null	0.599976	136	null	106	11	null	null	6	<2 mo. follow-up	6
4,680	76.646	1	male	0	10	558	CHF	COPD/CHF/Cirrhosis	2	10	under $11k	0	9,616	6,967.2773	6,610	11.5	white	21.796875	39	0.799927	0.677979	1	0	0	no	null	null	no dnr	10	68	19	105	8	39.29688	312	2.299805	1.099854	11.199219	132	7.359375	188	92	850	5	2	no(M2 and SIP pres)	2
4,681	61.89697	1	male	1	5	5	Coma	Coma	4	null	under $11k	100	25,350	14,670.7344	13,805	35	white	41.296875	75	0.001	0	5	0	0	no	0.01	0.01	dnr after sadm	4	112	21	105	28	36.39844	283.3125	1.799805	2.799805	0.699951	136	7.509766	124	48	3,280	null	null	<2 mo. follow-up	3.412109
4,682	38.83398	1	male	0	7	78	Lung Cancer	Cancer	1	16	$25-$50k	0	12,767	7,167.6797	5,134	5	white	13.699219	12	0.813965	0.600952	1	0	0	metastatic	0.7	0.4	no dnr	7	57	26	125	20	38.69531	78.75	2.599609	null	0.599976	133	7.299805	173	20	900	null	null	SIP>=30	1.891357
4,683	56.93399	0	male	0	23	880	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	178,049	106,424.438	118,616	27.333328	white	23.199219	31	0.726929	0.642944	36	0	0	yes	null	null	no dnr	23	117	6.899414	130	10	38.69531	140	1.199951	null	0.599976	133	7.40918	238	25	1,485	null	null	null	2.515625
4,684	63.26099	1	male	1	5	5	Coma	Coma	3	null	null	94	18,203	10,571.1016	8,207	43	black	19.597656	22	0.381958	0.307983	1	0	0	no	0	0	dnr after sadm	4	112	7.599609	120	10	36.29688	136	2.699707	0.199982	4.899414	148	7.379883	80	135	1,740	null	null	<2 mo. follow-up	2.70459
4,685	59.573	0	female	0	21	880	COPD	COPD/CHF/Cirrhosis	1	10	$25-$50k	0	28,897	18,869.1875	20,256	9	white	20.699219	15	0.863892	0.774902	3	0	0	no	null	null	no dnr	21	138	12	115	38	37.79688	220	1.899902	0.399963	5.399414	131	7.429688	114	72	780	null	null	null	2.867676
4,686	64.39398	1	male	0	11	576	MOSF w/Malig	ARF/MOSF	2	14	$25-$50k	0	51,695	30,432.25	34,388	29.5	white	23.597656	45	0.54895	0.435974	12	1	0	metastatic	null	null	no dnr	11	63	12.5	80	12	37.79688	180	2	0.799927	2.099609	137	7.379883	114	36	1,365	2	0	no(M2 and SIP pres)	0
4,687	64.02997	1	female	0	7	192	Colon Cancer	Cancer	1	20	null	0	13,248	7,570.4336	6,610	6.5	white	10.5	9	0.888916	0.745972	1	0	0	metastatic	0.9	0.8	no dnr	7	78	23.097656	120	44	38.29688	210	1.599854	3.899902	0.799927	129	7.489258	189	12	2,745	0	0	no(M2 and SIP pres)	0
4,688	39.53497	0	female	0	15	879	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$25-$50k	0	47,511	29,027.0781	32,729	26.333328	black	19.296875	19	0.914917	0.883911	1	0	0	no	null	null	no dnr	15	77	20.398438	120	24	38	118	null	0.699951	1.299805	135	7.439453	206	44	null	5	6	no(M2 and SIP pres)	6
4,689	53.76297	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	$11-$25k	0	57,148	null	null	39.5	white	29.898438	29	0.756958	0.678955	1	0	0	no	0.7	0.65	dnr after sadm	12	40	20.199219	155	8	38.09375	54	2.099609	1.599854	2	131	7.389648	71	40	1,570	null	0	<2 mo. follow-up	0
4,690	59.73999	1	male	0	14	805	CHF	COPD/CHF/Cirrhosis	2	6	under $11k	0	39,612	23,242.3281	21,152	17.666656	white	28.597656	41	0.72998	0.576904	4	0	0	no	0.8	0.65	dnr after sadm	10	47	22	130	35	39.19531	220	2.5	0.399963	0.5	140	7.40918	89	11	2,860	1	6	no(M2 and SIP pres)	6
4,691	63.685	1	female	0	5	94	Lung Cancer	Cancer	1	null	null	0	7,560	4,113.7734	2,824	14	white	14.898438	11	0.75	0.48999	1	0	0	metastatic	1	1	no dnr	5	82	8.398438	75	20	37.19531	null	4.099609	0.399963	0.799927	141	null	122	6	null	null	null	null	2.620606
4,692	54.94299	1	male	0	6	36	Lung Cancer	Cancer	1	12	null	0	9,718	5,279.8398	2,546	14	white	21.199219	13	0.643921	0.336975	1	0	0	metastatic	0.5	0.1	no dnr	6	83	5.799805	65	20	36.5	204.75	null	1.299805	0.899902	143	7.299805	197	18	null	null	null	<2 mo. follow-up	2.157715
4,693	62.146	1	male	1	27	27	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$25-$50k	9	216,076	122,452.875	101,511	49.25	white	33.195313	59	0.518921	0.401978	12	1	0	no	null	null	no dnr	27	80	7.199219	65	14	35.29688	null	null	0.899902	0.899902	139	null	93	19	null	null	5	<2 mo. follow-up	5
4,694	30.672	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	3	10	null	9	35,140	20,746.8125	20,754	35	black	39.59375	51	0.220978	0.122986	6	0	0	yes	0.2	0.1	dnr after sadm	4	77	21.597656	70	20	38.09375	null	null	0.399963	0.799927	139	null	173	9	2,625	null	0	<2 mo. follow-up	0
4,695	52.59998	0	male	0	7	875	CHF	COPD/CHF/Cirrhosis	2	15	$25-$50k	0	8,361	5,628.3125	5,935	7.5	white	22.5	41	0.870972	0.785889	1	0	0	no	null	null	no dnr	7	52	10.599609	125	26	39.19531	191.40625	null	6	5.5	145	7.399414	111	56	1,755	0	0	SIP>=30	0
4,696	67.685	1	female	0	39	49	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	55	null	41,386.75	42,966	21	black	23.296875	49	0.572998	0.461975	4	0	0	no	0.6	0.5	dnr after sadm	9	0	24.199219	0	0	36.5	413.3125	null	null	2.099609	143	7.40918	167	46	1,180	null	0	<2 mo. follow-up	0
4,697	75.85797	1	female	1	19	19	MOSF w/Malig	ARF/MOSF	1	13	$25-$50k	41	128,017	71,371.9375	68,692	52	white	31.398438	61	0.207977	0.112991	6	0	0	yes	0.1	0.05	dnr after sadm	3	69	null	68	12	36.19531	null	null	null	null	140	null	null	null	null	null	0	<2 mo. follow-up	0
4,698	68.40796	1	female	0	102	465	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	null	206,201.625	221,725	45.75	white	25	45	0.753906	0.675903	3	1	0	no	0.2	0.15	no dnr	102	0	18.699219	0	32	38.59375	69	1.199951	null	6.399414	141	7.289062	154	82	1,560	null	0	adl>=4 (>=5 if sur)	0
4,699	51.23297	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	61	18,435	11,561.6641	10,092	24.5	black	24.597656	41	0.661987	0.563965	1	0	0	no	0.6	0.55	dnr after sadm	3	78	5.699219	50	24	36.69531	null	null	0.599976	0.799927	139	null	93	8	null	null	7	<2 mo. follow-up	7
4,700	63.655	1	male	0	5	271	CHF	COPD/CHF/Cirrhosis	2	14	null	0	3,472	2,695.6484	2,398	6	black	23.597656	20	0.824951	0.713989	1	1	0	no	0.8	0.5	no dnr	5	78	6.199219	65	20	37.29688	null	null	25.5	1	136	null	115	8	1,500	0	null	no(M2 and SIP pres)	0.494751

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.